[Are maintenance substitution practices indicated in the framework of health care of drug addicts?].
Déglon
J J
JJ
Fondation Phénix, Chêne-Bougeries, Suisse.
D002047:Buprenorphine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003932:Heroin / Q000009:adverse effects; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D008691:Methadone / Q000008:administration & dosage / Q000627:therapeutic use*; D009294:Narcotics / Q000009:adverse effects; D011788:Quality of Life; D012944:Social Support; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders / Q000534:rehabilitation*; D013997:Time Factors
D009294:Narcotics; D002047:Buprenorphine; D003932:Heroin; D008691:Methadone
Dans le cadre de la prise en charge thérapeutique des toxicomanes, les pratiques de substitution sont-elles indiquées comme maintenance?